Inventor

VAN BLARCOM THOMAS JOHN

US25 patents

⚠️ This page may combine multiple inventors who share the name “VAN BLARCOM THOMAS JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VAN BLARCOM THOMAS JOHN

PFIZER

Therapeutic antibodies and their uses

Chimeric antigen receptors targeting B-cell maturation antigen

Therapeutic antibodies and their uses

Antibodies specific for CD70 and their uses

Therapeutic antibodies and their uses

Therapeutic antibodies and their uses

Therapeutic antibodies and their uses

Chimeric antigen receptors targeting B-cell maturation antigen

Chimeric antigen receptors targeting CD70

Chimeric antigen receptors targeting B-cell maturation antigen

Antibodies specific for CD70 and their uses

Antibodies specific for CD47, PD-L1, and uses thereof

ALLOGENE THERAPEUTICS INC

DLL3 targeting chimeric antigen receptors and binding agents

Chimeric antigen receptors with enhanced signaling and activities and uses thereof

Constitutively active chimeric cytokine receptors

Chimeric cytokine receptors bearing a PD-1 ectodomain

Modified caspase-9 polypeptides and methods of use thereof

Modified caspase-9 polypeptides and methods of use thereof

Protease-activating CD45-gate CAR

FasL expression and FasR gene knockout to protect therapeutic cells from allogeneic rejection and activation-induced cell death

Chimeric cytokine receptors comprising TGF β binding domains

BCMA CAR-T cells with enhanced activities

Inducible chimeric cytokine receptors

Knockdown or knockout of one or more of TAP2, NLRC5, B2m, TRAC, RFX5, RFXAP and RFXANK to mitigate t cell recognition of allogeneic cell products

RINAT NEUROSCIENCE CORP

Anti-glucagon receptor antibodies and pharmaceutical compositions thereof